BioCentury | Oct 15, 2003
Company News

Rice named CEO of Cylene

...was named president, CEO and a director of cancer company Cylene (San Diego, Calif.), formerly Cyternex...
BioCentury | Aug 26, 2002
Tools & Techniques

Picking the right seat in cancer

...oncogene based on the formation of a regulatory element within c-myc's promoter region. Researchers from Cyternex Inc....
...repressing transcription of c-myc. Laurence Hurley, an author on the paper and scientific director of Cyternex...
...resulting in compounds more potent than TMPyP4. These compounds will be tested in animal models. Cyternex...
BioCentury | Aug 26, 2002
Company News

Cyternex other research news

...that a small molecule that stabilizes this structure represses the transcription of the c-myc gene. Cyternex Inc....
Items per page:
1 - 3 of 3
BioCentury | Oct 15, 2003
Company News

Rice named CEO of Cylene

...was named president, CEO and a director of cancer company Cylene (San Diego, Calif.), formerly Cyternex...
BioCentury | Aug 26, 2002
Tools & Techniques

Picking the right seat in cancer

...oncogene based on the formation of a regulatory element within c-myc's promoter region. Researchers from Cyternex Inc....
...repressing transcription of c-myc. Laurence Hurley, an author on the paper and scientific director of Cyternex...
...resulting in compounds more potent than TMPyP4. These compounds will be tested in animal models. Cyternex...
BioCentury | Aug 26, 2002
Company News

Cyternex other research news

...that a small molecule that stabilizes this structure represses the transcription of the c-myc gene. Cyternex Inc....
Items per page:
1 - 3 of 3